Glasgow prognostic score as a predictor of decompensation in patients with primary biliary cholangitis

Table 4 Association between Glasgow prognostic scores and decompensation risk, stratified by model for end-stage liver disease score

Variable	Univariate analysis		Multivariate analysis
			Model A		Model B		Model C
	HR (95%CI)	P value	HR (95%CI)	P value	HR (95%CI)	P value	HR (95%CI)	P value
MELD ≥ 10
GPS	3.173 (2.142-4.698)	< 0.001	3.024 (2.017-4.534)	< 0.001	3.072 (2.041-4.623)	< 0.001	3.521 (2.215-5.597)	< 0.001
mGPS	2.683 (2.000-3.599)	< 0.001	2.592 (1.909-3.519)	< 0.001	2.629 (1.933-3.577)	< 0.001	3.014 (2.113-4.299)	< 0.001
hs-mGPS	2.205 (1.584-3.069)	< 0.001	2.115 (1.499-2.984)	< 0.001	2.096 (1.485-2.959)	< 0.001	2.207 (1.509-3.226)	< 0.001
MELD < 10
GPS	3.598 (2.618-4.943)	< 0.001	3.484 (2.519-4.817)	< 0.001	3.673 (2.648-5.094)	< 0.001	3.982 (2.768-5.729)	< 0.001
mGPS	3.266 (2.407-4.431)	< 0.001	3.101 (2.278-4.221)	< 0.001	3.217 (2.345-4.413)	< 0.001	3.685 (2.569-5.288)	< 0.001
hs-mGPS	3.937 (2.909-5.328)	< 0.001	3.846 (2.821-5.244)	< 0.001	4.132 (2.997-5.697)	< 0.001	4.347 (3.069-6.159)	< 0.001

CI: Confidence interval; GPS: Glasgow prognostic score; HR: Hazard ratio; hs-mGPS: High-sensitivity modified Glasgow prognostic score; MELD: Model for end-stage liver disease; mGPS: Modified Glasgow prognostic score.